Accelerating Antibody Development with Automated Octet Assays
White Paper Mar 11, 2019
Drug development and production is challenging, however, high throughput characterization systems can greatly accelerate discovery programs.
Using a proprietary discovery and development platform technology, Avitide enables its partners to rapidly advance candidate molecules to the clinic and achieve faster and more predictable bioprocess development timelines.
Download this whitepaper to discover the key considerations for automated Octet assays.
Related White Papers
Download this compendium to learn more about fragment analyzers and how these are applied to workflows.
READ MOREDownload this whitepaper to understand more about how automated sample storage can aid in the research of COVID-19.
READ MOREDownload this whitepaper to learn more about the selection of cell models and paints for the process of cellular painting.
READ MORELike what you just read? You can find similar content on the communities below.
Biopharma Cell Science DiagnosticsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
